Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Tocilizumab for Painful Chronic Pancreatitis: A Randomised, Placebo-Controlled, Double-blinded, Investigator Initiated Trial (TOPAC Trial)

NCT06426160 is registered in ClinicalTrials.gov with Soren Schou Olesen as lead sponsor.

NCT NCT06426160
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06426160 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Tocilizumab for Painful Chronic Pancreatitis: A Randomised, Placebo-Controlled, Double-blinded, Investigator Initiated Trial (TOPAC Trial)
Lead sponsor
Soren Schou Olesen
Phase
Phase 2
Overall status
Active, not recruiting
Start date
May 21, 2024
Completion date
October 31, 2026
Enrollment
32 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pancreatitis, chronic